Concepedia

Reena Khanna

RK

Statistics

Publications

11

Citations

639

H-Index

11

Active since

2014

Affiliations

Western University(Current)

Robarts Clinical Trials

University of California San Diego

University of Calgary

University of Toronto

Reena Khanna is an author at Western University specializing in inflammatory bowel disease, gastrointestinal inflammation, and medicine.

Publications per year

2014–2021

11

Publications

11

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Niels Vande Casteele, Reena Khanna, Barrett G. Levesque et al. · Gut · 2014 · 286 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

Vipul Jairath, Laurent Peyrin‐Biroulet, Guangyong Zou et al. · Gut · 2018 · 62 citations · Full text

Medicine, Clinical Sciences, Pathology +17

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

Parambir S. Dulai, Vipul Jairath, Reena Khanna et al. · Alimentary Pharmacology & Therapeutics · 2020 · 52 citations · Full text

Medicine, Clinical Sciences, Pharmacoeconomics +16

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease

Gregor Novak, Toer Stevens, Tanja van Viegen et al. · Alimentary Pharmacology & Therapeutics · 2019 · 30 citations · Full text

Medicine, Clinical Sciences, Pathology +17

1–5 of 11